- Home
- OTLK vs SYPR Comparison
OTLK vs SYPR Comparison
Compare OTLK & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- SYPR
- Stock Information
- Founded
- OTLK 2010
- SYPR 1997
- Country
- OTLK United States
- SYPR United States
- Employees
- OTLK N/A
- SYPR N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- SYPR Industrial Machinery/Components
- Sector
- OTLK Health Care
- SYPR Industrials
- Exchange
- OTLK Nasdaq
- SYPR Nasdaq
- Market Cap
- OTLK 42.8M
- SYPR 47.9M
- IPO Year
- OTLK 2016
- SYPR 1994
- Fundamental
- Price
- OTLK $1.46
- SYPR $2.18
- Analyst Decision
- OTLK Buy
- SYPR
- Analyst Count
- OTLK 5
- SYPR 0
- Target Price
- OTLK $5.25
- SYPR N/A
- AVG Volume (30 Days)
- OTLK 2.5M
- SYPR 32.6K
- Earning Date
- OTLK 08-14-2025
- SYPR 11-11-2025
- Dividend Yield
- OTLK N/A
- SYPR N/A
- EPS Growth
- OTLK N/A
- SYPR N/A
- EPS
- OTLK N/A
- SYPR N/A
- Revenue
- OTLK $1,505,322.00
- SYPR $130,040,000.00
- Revenue This Year
- OTLK N/A
- SYPR N/A
- Revenue Next Year
- OTLK $313.69
- SYPR N/A
- P/E Ratio
- OTLK N/A
- SYPR N/A
- Revenue Growth
- OTLK N/A
- SYPR N/A
- 52 Week Low
- OTLK $0.79
- SYPR $1.30
- 52 Week High
- OTLK $6.98
- SYPR $3.72
- Technical
- Relative Strength Index (RSI)
- OTLK 62.88
- SYPR 51.75
- Support Level
- OTLK $1.18
- SYPR $2.12
- Resistance Level
- OTLK $1.30
- SYPR $2.45
- Average True Range (ATR)
- OTLK 0.10
- SYPR 0.15
- MACD
- OTLK 0.07
- SYPR -0.01
- Stochastic Oscillator
- OTLK 83.63
- SYPR 53.33
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.